Bertozzi Carolyn R
SEC insider (Form 3/4/5 filer). CIK 0001698766. 10% Owner at Lycia Therapeutics, Inc. (LYCA) and 3 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Bertozzi Carolyn R has filed insider reports for
- Lycia Therapeutics, Inc. (LYCA): 10% Owner
- OmniAb, Inc. (OABI): Director
- ELI LILLY & Co (LLY): Director
- ALNYLAM PHARMACEUTICALS, INC. (ALNY): Director
Bertozzi Carolyn R
CIK: 0001698766
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jun 17, 2026OABI
OmniAb, Inc.
ExerciseDirect20K shares- - Jun 17, 2026OABI
OmniAb, Inc.
AwardDirectRestricted Stock Units
20K shares- - Jun 17, 2026OABI
OmniAb, Inc.
AwardDirectStock Option (right to buy)
40K shares- - Nov 1, 2025OABI
OmniAb, Inc.
ExerciseDirect17.8K shares- - Jun 17, 2025OABI
OmniAb, Inc.
AwardDirectRestricted Stock Units
20K shares- - Jun 17, 2025OABI
OmniAb, Inc.
AwardDirectStock Option (right to buy)
40K shares- - Jun 17, 2025OABI
OmniAb, Inc.
ExerciseDirect20K shares- - May 8, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
AwardDirect775 shares- - Nov 1, 2024OABI
OmniAb, Inc.
ExerciseDirect17.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  OABI OmniAb, Inc. | Exercise | 20,000 | - | $0 | Direct |
| Jun 17, 2026 | OABI OmniAb, Inc. | Award Restricted Stock Units | 20,000 | - | - | Direct |
| Jun 17, 2026 | OABI OmniAb, Inc. | Award Stock Option (right to buy) | 40,000 | - | - | Direct |
| Nov 1, 2025 | OABI OmniAb, Inc. | Exercise | 17,769 | - | - | Direct |
| Jun 17, 2025 | OABI OmniAb, Inc. | Award Restricted Stock Units | 20,000 | - | - | Direct |
| Jun 17, 2025 | OABI OmniAb, Inc. | Award Stock Option (right to buy) | 40,000 | - | - | Direct |
| Jun 17, 2025 | OABI OmniAb, Inc. | Exercise | 20,000 | - | - | Direct |
| May 8, 2025 |  ALNY ALNYLAM PHARMACEUTICALS, INC. | Award | 775 | - | - | Direct |
| Nov 1, 2024 | OABI OmniAb, Inc. | Exercise | 17,769 | - | $0 | Direct |
1-9 of 9 transactions